Shandong researchers suggest that edible and medicinal fungi contain bioactive components with therapeutic potential for ...

Protagenic Therapeutics shares soared 240% Monday on its all-stock merger with Phytanix Bio. New Phytanix targets CNS disorders with an expanded diverse pipeline and experienced team.

Discover the major causes of partial paralysis from stroke and trauma to inflammatory conditions and tumors, plus warning ...

Neurological disorders, including neurosurgical conditions and various neurological diseases, are often associated with ...

The following is a summary of “Predicting intrathecal immunoglobulin synthesis in the ICU: a comparative study of IgG-based ...

Shares of Protagenic Therapeutics, Inc. (PTIX) jumped 244% on Monday morning after the company announced its merger with ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

The antitumour response we uncovered in the leptomeninges raises the possibility that other immune responses there might diverge from their typical behaviour outside the central nervous system.

A NEW PUBLICATION IN THE SCIENTIFIC JOURNAL PLOS ONE, SHOWS THAT MASITINIB CAN LOWER SERUM NEUROFILAMENT LIGHT CHAIN, AN IMPORTANT BIOMARKER FOR NEURODEGENERATIVE DISORDERS, INCLUDING MULTIPLE ...